molecular imaging
DeepGlioma has shown it can classify brain tumors on the spot during surgery, and experts believe the AI-based imaging system can be useful for informing precision care.
Telix Acquires Exclusive Worldwide Rights to Eli Lilly's Olaratumab
Telix is picking up a license to a radiolabeled form of Lilly's withdrawn cancer antibody olaratumab, aiming to capitalize on its use as a theranostic for soft tissue sarcoma.
Telix Partners With Kettering Health to Further Study of PSMA-Targeting Radioligand Therapy
The partners aim to further explore the activity of Telix's radiopharmaceuticals and make Kettering Health a regional hub for molecular imaging and theranostics.
GE Healthcare Acquiring Zionexa for Access to Breast Cancer PET Imaging Agent
GE intends to scale access to the PET imaging agent so at least 75 percent of metastatic breast cancer patients in the US have access to it by 2023.
ImaginAb, Neuvogen Sign Deal to Use CD8 ImmunoPET Technology in Cancer Vaccine Trials
ImaginAb will implement its PET imaging technology in trials to monitor and confirm the activity of Neuvogen's therapeutic vaccines.